Dermatology

Advancing skin disease treatments

Skin Disease Research

Our dermatology program encompasses clinical trials for inflammatory skin conditions, skin cancer, aesthetic treatments, and rare dermatological disorders with validated assessment tools.

Research Focus

Atopic dermatitis trials
Psoriasis studies
Acne and rosacea research
Melanoma and skin cancer
Wound healing studies
Cosmetic dermatology trials

Foundational Technologies & Key Targets

Molecular Targets

IL-17 & IL-23: Key inflammatory cytokines driving psoriasis pathogenesis, targeted by highly effective biologic therapies.

JAK Pathways: Janus kinase pathways involved in multiple inflammatory skin conditions, targeted by oral small molecule inhibitors.

IL-4/IL-13: Interleukins central to atopic dermatitis, targeted by dupilumab and other biologics.

Therapeutic Approaches

Biologics: Monoclonal antibodies targeting IL-17, IL-23, and IL-4/IL-13 pathways for moderate-to-severe psoriasis and atopic dermatitis. JAK Inhibitors: Small molecule oral and topical therapies blocking inflammatory signaling. Topical Therapies: Advanced formulations including PDE4 inhibitors and novel corticosteroid alternatives.

Gene Therapy Applications

Ex Vivo Gene Therapy: Developing treatments for genetic skin disorders like Epidermolysis Bullosa by modifying patient skin cells to correct genetic defects, then grafting corrected tissue. Gene Editing: Exploring CRISPR approaches for inherited skin conditions affecting keratinocyte function and skin barrier integrity.

Specialized Assessment

We employ validated dermatological scoring systems, digital imaging, biopsy analysis, and quality of life assessments to comprehensively evaluate treatment outcomes.

Integrated Research Excellence

Dermatology trials thrive on our integrated approach to specialized endpoints. Clinical Trials Management coordinates trials with trained dermatological assessors and standardized photographic documentation protocols. Data Management expertly captures visual analog scales, dermatology quality of life indices, and digital imaging data with precision. Quality Assurance ensures consistency in dermatological scoring and image quality across sites. Biostatistics analyzes complex dermatological endpoints and patient-reported outcomes. Regulatory Affairs navigates dermatology-specific regulatory requirements, and Medical Writing creates comprehensive clinical study reports with integrated visual documentation.